Metoclopramide Injection, Solution
FDA Label NDC 55154-0450

55 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Metoclopramide (NDC 55154-0450). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: tardive dyskinesia, description, clinical pharmacology, pharmacokinetics, diabetic gastroparesis, the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, the prevention of postoperative nausea and vomiting, small bowel intubation, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package/Label Display Panel

NDC 55154-0450-5

METOCLOPRAMIDE INJECTION USP

10 mg/2 mL (5 mg/mL)

5 x 2 mL SINGLE-DOSE VIALS

10mg/2ml Bag Label (E4deb814 Efe2 4ed2 84e6 Fc9cde89d9e5 00)

10mg/2ml Bag Label (E4deb814 Efe2 4ed2 84e6 Fc9cde89d9e5 00)

* Please review the disclaimer below.